跳至主要内容
临床试验/NCT00869492
NCT00869492Unknown3 期

A Double Blind Randomised Comparison of Nadifloxacin 1% Cream Alone and Nadifloxacine %1 Cream With Benzoyl Peroxide 5% Solution in the Treatment of Mild to Moderate Facial Acne Vulgaris

Marmara University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2008年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
90
试验地点
1
主要终点
Number of patients whom inflammatory lesions were decreased %50 or more

研究概览

简要总结

The purpose of this study is to determine whether using of nadifloxacine 1% cream and benzoyl peroxide 5% solution together is more effective than using nadifloxacine alone in the treatment of mild to moderate facial acne.

详细描述

Nadifloxacin; a new topical antibiotic for the treatment of acne has recently been marketed in our country. Only a few studies on its use and effectiviness could be found in the literature. Nadifloxacin may be an alternative to other topical antibiotics and benzoyl peroxide or its use along with benzoyl peroxide may be more effective and rational to prevent possible future resistance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
14 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of mild to moderate facial acne vulgaris
  • Must have at least 10 inflammatory and/or non-inflammatory and no more than 3 nodulocystic acne lesions

排除标准

  • Nodulocystic acne lesions more than 3 and pure comedonal acne
  • Additional truncal acne needs systemic therapy
  • Usage of topical treatments for acne in last 2 weeks, systemic antibiotic in last 4 weeks, systemic isotretinoin in last 6 months
  • Application of chemical peels and laser in last 4 weeks
  • Usage of hormones in last 3 months
  • Clinical signs of hyperandrogenism in females
  • Pregrancy and lactation
  • Hypersensitivity to interventions
  • Additional facial skin diseases (eg. atopic and seborreic dermatitis)
  • Photosensitive disorders and usage of drugs which can trigger Photosensitive conditions

研究组 & 干预措施

A

Other

instructed nadifloxacine 1% cream twice dailly, and placebo for benzoyl peroxide 5% solution once dailly

干预措施: nadifloxacine (Drug)

B

Other

instructed nadifloxacine 1% cream twice dailly, and active benzoyl peroxide 5% solution once dailly

干预措施: benzoyl peroxide (Drug)

B

Other

instructed nadifloxacine 1% cream twice dailly, and active benzoyl peroxide 5% solution once dailly

干预措施: nadifloxacine (Drug)

结局指标

主要结局

Number of patients whom inflammatory lesions were decreased %50 or more

时间窗: two months

次要结局

  • the number of patients whom were observed side effects(two months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验